Expression of TET1 Gene in Acute Leukaemia
NCT03267485 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2017-08-30
Summary
The aim of the present study is to detect the expression of TET 1 gene in patients with acute leukemia and its correlation with clinical and pathological criteria of the patients.
Conditions
Interventions
- DEVICE
-
real time PCR
Real Time PCR is based on the detection of the fluorescence produced by a reporter molecule which increases, as the reaction proceeds. These fluorescent reporter molecules include dyes that bind to the double-stranded DNA or sequence specific probes . Moreover, there is no need for the post PCR processing which saves the resources and the time. .
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-01
- Primary Completion
- 2018-11-30
- Completion
- 2018-12-31
More Related Trials
-
Immunophenotyping and Xist Gene in AML
NCT04288739 ·Status: UNKNOWN
-
Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia
NCT01245231 ·Status: COMPLETED
-
Leukemia Cell Cultures for Research of New Anti-Cancer Therapies
NCT00993538 ·Status: UNKNOWN ·Phase: NA
-
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
NCT01311258 ·Status: RECRUITING
-
Relation of C-reactive Protein/ Albumin Ratio and Coagulation Profile in Acute Myeloid Leukemia Patients
NCT06714071 ·Status: NOT_YET_RECRUITING
-
Feasibility Study of Intermediate Doses of ARA-C With Autologous SCT as Consolidation of Low/Intermediate-risk AML
NCT03023384 ·Status: UNKNOWN
-
Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients
NCT00631059 ·Status: TERMINATED ·Phase: NA
-
Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy
NCT03728699 ·Status: COMPLETED
-
Feasibility and Safety of Home Blood Count Measurement and Transfusions in Patients With Acute Myeloid Leukemia
NCT07062250 ·Status: RECRUITING ·Phase: NA
-
Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine
NCT06060782 ·Status: RECRUITING ·Phase: PHASE1
-
High-dose Cytarabine and Survival in AML
NCT01034839 ·Status: COMPLETED
-
Assessment of Antithrombin III, Protein C, Protein S and D-dimer in Acute Leukemia
NCT07036809 ·Status: COMPLETED
-
Analysis of T Cell Metabolism in Acute Myeloid Leukemia Patients
NCT04259372 ·Status: COMPLETED
-
All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT00151255 ·Status: COMPLETED ·Phase: PHASE3
-
FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid Leukemia.
NCT05383014 ·Status: UNKNOWN
-
Molecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic Treatments
NCT06764459 ·Status: RECRUITING
-
FoxO3a and PU.1 in Acute Lymphoblastic Leukemia
NCT04092348 ·Status: UNKNOWN
-
Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
NCT00002514 ·Status: COMPLETED ·Phase: PHASE3
-
Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients
NCT07250217 ·Status: RECRUITING ·Phase: NA
-
Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?
NCT07069933 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute Leukemia
NCT02345915 ·Status: UNKNOWN ·Phase: NA
-
Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) Patients
NCT01015261 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage
NCT04440267 ·Status: RECRUITING ·Phase: PHASE2
-
Observational Trial of a Therapeutic Platelet Transfusion Regimen
NCT02276651 ·Status: TERMINATED
-
Chronic Myelod Leukemia Registry at Asan Medical Center
NCT01761695 ·Status: TERMINATED